Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study
- 18 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Perinatology
- Vol. 42 (9) , 1161-1168
Abstract
Objective The short and long-term outcomes of children with anti-Ro/La-related congenital heart block treated with a combined maternal-neonatal therapy protocol were compared with those of controls treated with other therapies. Study design Sixteen mothers were treated during pregnancy with a therapy consisting of daily oral fluorinated steroids, weekly plasma exchange and fortnightly intravenous immunoglobulins and their neonates with intravenous immunoglobulins (study group); 19 mothers were treated with fluorinated steroids alone or associated to intravenous immunoglobulins or plasma exchange (control group). Result The combined-therapy children showed a significantly lower progression rate from 2nd to 3rd degree block at birth, a significant increase in heart rate at birth and a significantly lower number of pacemaker implants during post-natal follow-up with respect to those treated with the other therapies. Conclusion The combined therapy produced better short and long term outcomes with respect to the other therapies studied.Keywords
This publication has 42 references indexed in Scilit:
- Antenatal and postnatal combined therapy for autoantibody-related congenital atrioventricular blockBMC Pregnancy and Childbirth, 2013
- Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpuraVox Sanguinis, 2013
- Congenital heart block: evidence for a pathogenic role of maternal autoantibodiesArthritis Research & Therapy, 2012
- Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune‐associated congenital heart blockArthritis & Rheumatism, 2011
- Congenital Fetal Heart Block: a Potential Therapeutic Role for Intravenous ImmunoglobulinObstetrics & Gynecology, 2011
- Congenital Fetal Heart BlockObstetrics & Gynecology, 2010
- Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) StudyThe American Journal of Cardiology, 2009
- Therapeutic Apheresis—State of the Art in the Year 2005Therapeutic Apheresis and Dialysis, 2005
- Anti-SSA/Ro-related congenital heart block in two family members of different generations: Comment on the article by Clancy et alArthritis & Rheumatism, 2005
- Calcification of the Atrioventricular Node in a Fetus Affected by Congenital Complete Heart BlockCirculation, 2002